Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures.

Mult Scler J Exp Transl Clin · 2015 · PMC5433328 · PMID 28607711

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Two baseline predictors were significant, higher CSF NFL and CEL number, with a strong trend towards the CSF CXCL13 index being predictive as well.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.